Global Injectable Bone Graft 麻豆原创 2025 by Company, Regions, Type and Application, Forecast to 2031

Publication ID:

GIR072510881

Publication Date:

July 22, 2025

Pages:

117

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Injectable Bone Graft market size was valued at US$ 725 million in 2024 and is forecast to a readjusted size of USD 1018 million by 2031 with a CAGR of 5.0% during review period.
An injectable bone graft refers to a biomaterial that can be delivered in a fluid or paste-like form directly into a surgical site, typically to promote bone regeneration or fusion. These grafts are often used in orthopedic and dental procedures where there is a need to fill voids, defects, or gaps in bone tissue. Injectable bone grafts can contain various components such as ceramics, polymers, growth factors, or bone-derived materials that facilitate new bone formation and integration with existing bone structures. Their injectable nature allows surgeons to precisely place the graft material into complex or minimally invasive surgical sites, enhancing surgical outcomes and patient recovery.
Global key players of Injectable Bone Graft include Medtronic, DePuy Synthes, Baxter, Stryker (Wright Medical), BONESUPPORT, etc. The top five players hold a share about 60%. North America is the largest market, and has a share about 74%, followed by Europe and Asia-Pacific with share 18% and 5%, separately. In terms of product type, Synthetic is the largest segment, accounting for a share of 77%. In terms of application, Hospital is the largest field with a share about 66 percent.
This report is a detailed and comprehensive analysis for global Injectable Bone Graft market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Injectable Bone Graft market size and forecasts, in consumption value ($ Million), 2020-2031
Global Injectable Bone Graft market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Injectable Bone Graft market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Injectable Bone Graft market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Injectable Bone Graft
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Injectable Bone Graft market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, DePuy Synthes, Baxter, Stryker (Wright Medical), BONESUPPORT, Xtant Medical, SeaSpine, Zimmer Biomet, Biocomposites, Anika, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Injectable Bone Graft market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Natural
Synthetic
麻豆原创 segment by Application
Hospital
Clinic
麻豆原创 segment by players, this report covers
Medtronic
DePuy Synthes
Baxter
Stryker (Wright Medical)
BONESUPPORT
Xtant Medical
SeaSpine
Zimmer Biomet
Biocomposites
Anika
ORD
Biomatlante
Graftys
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Injectable Bone Graft product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Injectable Bone Graft, with revenue, gross margin, and global market share of Injectable Bone Graft from 2020 to 2025.
Chapter 3, the Injectable Bone Graft competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Injectable Bone Graft market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Injectable Bone Graft.
Chapter 13, to describe Injectable Bone Graft research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Injectable Bone Graft by Type
1.3.1 Overview: Global Injectable Bone Graft 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Injectable Bone Graft Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 Natural
1.3.4 Synthetic
1.4 Global Injectable Bone Graft 麻豆原创 by Application
1.4.1 Overview: Global Injectable Bone Graft 麻豆原创 Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Injectable Bone Graft 麻豆原创 Size & Forecast
1.6 Global Injectable Bone Graft 麻豆原创 Size and Forecast by Region
1.6.1 Global Injectable Bone Graft 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Injectable Bone Graft 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America Injectable Bone Graft 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe Injectable Bone Graft 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Injectable Bone Graft 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America Injectable Bone Graft 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Injectable Bone Graft 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Injectable Bone Graft Product and Solutions
2.1.4 Medtronic Injectable Bone Graft Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Medtronic Recent Developments and Future Plans
2.2 DePuy Synthes
2.2.1 DePuy Synthes Details
2.2.2 DePuy Synthes Major Business
2.2.3 DePuy Synthes Injectable Bone Graft Product and Solutions
2.2.4 DePuy Synthes Injectable Bone Graft Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 DePuy Synthes Recent Developments and Future Plans
2.3 Baxter
2.3.1 Baxter Details
2.3.2 Baxter Major Business
2.3.3 Baxter Injectable Bone Graft Product and Solutions
2.3.4 Baxter Injectable Bone Graft Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Baxter Recent Developments and Future Plans
2.4 Stryker (Wright Medical)
2.4.1 Stryker (Wright Medical) Details
2.4.2 Stryker (Wright Medical) Major Business
2.4.3 Stryker (Wright Medical) Injectable Bone Graft Product and Solutions
2.4.4 Stryker (Wright Medical) Injectable Bone Graft Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Stryker (Wright Medical) Recent Developments and Future Plans
2.5 BONESUPPORT
2.5.1 BONESUPPORT Details
2.5.2 BONESUPPORT Major Business
2.5.3 BONESUPPORT Injectable Bone Graft Product and Solutions
2.5.4 BONESUPPORT Injectable Bone Graft Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 BONESUPPORT Recent Developments and Future Plans
2.6 Xtant Medical
2.6.1 Xtant Medical Details
2.6.2 Xtant Medical Major Business
2.6.3 Xtant Medical Injectable Bone Graft Product and Solutions
2.6.4 Xtant Medical Injectable Bone Graft Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Xtant Medical Recent Developments and Future Plans
2.7 SeaSpine
2.7.1 SeaSpine Details
2.7.2 SeaSpine Major Business
2.7.3 SeaSpine Injectable Bone Graft Product and Solutions
2.7.4 SeaSpine Injectable Bone Graft Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 SeaSpine Recent Developments and Future Plans
2.8 Zimmer Biomet
2.8.1 Zimmer Biomet Details
2.8.2 Zimmer Biomet Major Business
2.8.3 Zimmer Biomet Injectable Bone Graft Product and Solutions
2.8.4 Zimmer Biomet Injectable Bone Graft Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Zimmer Biomet Recent Developments and Future Plans
2.9 Biocomposites
2.9.1 Biocomposites Details
2.9.2 Biocomposites Major Business
2.9.3 Biocomposites Injectable Bone Graft Product and Solutions
2.9.4 Biocomposites Injectable Bone Graft Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Biocomposites Recent Developments and Future Plans
2.10 Anika
2.10.1 Anika Details
2.10.2 Anika Major Business
2.10.3 Anika Injectable Bone Graft Product and Solutions
2.10.4 Anika Injectable Bone Graft Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Anika Recent Developments and Future Plans
2.11 ORD
2.11.1 ORD Details
2.11.2 ORD Major Business
2.11.3 ORD Injectable Bone Graft Product and Solutions
2.11.4 ORD Injectable Bone Graft Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 ORD Recent Developments and Future Plans
2.12 Biomatlante
2.12.1 Biomatlante Details
2.12.2 Biomatlante Major Business
2.12.3 Biomatlante Injectable Bone Graft Product and Solutions
2.12.4 Biomatlante Injectable Bone Graft Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Biomatlante Recent Developments and Future Plans
2.13 Graftys
2.13.1 Graftys Details
2.13.2 Graftys Major Business
2.13.3 Graftys Injectable Bone Graft Product and Solutions
2.13.4 Graftys Injectable Bone Graft Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 Graftys Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Injectable Bone Graft Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of Injectable Bone Graft by Company Revenue
3.2.2 Top 3 Injectable Bone Graft Players 麻豆原创 Share in 2024
3.2.3 Top 6 Injectable Bone Graft Players 麻豆原创 Share in 2024
3.3 Injectable Bone Graft 麻豆原创: Overall Company Footprint Analysis
3.3.1 Injectable Bone Graft 麻豆原创: Region Footprint
3.3.2 Injectable Bone Graft 麻豆原创: Company Product Type Footprint
3.3.3 Injectable Bone Graft 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Injectable Bone Graft Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global Injectable Bone Graft 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by Application
5.1 Global Injectable Bone Graft Consumption Value 麻豆原创 Share by Application (2020-2025)
5.2 Global Injectable Bone Graft 麻豆原创 Forecast by Application (2026-2031)
6 North America
6.1 North America Injectable Bone Graft Consumption Value by Type (2020-2031)
6.2 North America Injectable Bone Graft 麻豆原创 Size by Application (2020-2031)
6.3 North America Injectable Bone Graft 麻豆原创 Size by Country
6.3.1 North America Injectable Bone Graft Consumption Value by Country (2020-2031)
6.3.2 United States Injectable Bone Graft 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada Injectable Bone Graft 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico Injectable Bone Graft 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe Injectable Bone Graft Consumption Value by Type (2020-2031)
7.2 Europe Injectable Bone Graft Consumption Value by Application (2020-2031)
7.3 Europe Injectable Bone Graft 麻豆原创 Size by Country
7.3.1 Europe Injectable Bone Graft Consumption Value by Country (2020-2031)
7.3.2 Germany Injectable Bone Graft 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France Injectable Bone Graft 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom Injectable Bone Graft 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia Injectable Bone Graft 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy Injectable Bone Graft 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Injectable Bone Graft Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Injectable Bone Graft Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Injectable Bone Graft 麻豆原创 Size by Region
8.3.1 Asia-Pacific Injectable Bone Graft Consumption Value by Region (2020-2031)
8.3.2 China Injectable Bone Graft 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan Injectable Bone Graft 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea Injectable Bone Graft 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India Injectable Bone Graft 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia Injectable Bone Graft 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia Injectable Bone Graft 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America Injectable Bone Graft Consumption Value by Type (2020-2031)
9.2 South America Injectable Bone Graft Consumption Value by Application (2020-2031)
9.3 South America Injectable Bone Graft 麻豆原创 Size by Country
9.3.1 South America Injectable Bone Graft Consumption Value by Country (2020-2031)
9.3.2 Brazil Injectable Bone Graft 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina Injectable Bone Graft 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Injectable Bone Graft Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Injectable Bone Graft Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Injectable Bone Graft 麻豆原创 Size by Country
10.3.1 Middle East & Africa Injectable Bone Graft Consumption Value by Country (2020-2031)
10.3.2 Turkey Injectable Bone Graft 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Injectable Bone Graft 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE Injectable Bone Graft 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 Injectable Bone Graft 麻豆原创 Drivers
11.2 Injectable Bone Graft 麻豆原创 Restraints
11.3 Injectable Bone Graft Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Injectable Bone Graft Industry Chain
12.2 Injectable Bone Graft Upstream Analysis
12.3 Injectable Bone Graft Midstream Analysis
12.4 Injectable Bone Graft Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Medtronic
DePuy Synthes
Baxter
Stryker (Wright Medical)
BONESUPPORT
Xtant Medical
SeaSpine
Zimmer Biomet
Biocomposites
Anika
ORD
Biomatlante
Graftys

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.